Study of disordered mesoporous silica regarding intrinsic compound affinity to the carrier and drug-accessible surface area

dc.contributor.authorNiederquell, Andreas
dc.contributor.authorVraníková, Barbora
dc.contributor.authorKuentz, Martin
dc.date.accessioned2024-02-08T09:43:28Z
dc.date.available2024-02-08T09:43:28Z
dc.date.issued2023
dc.description.abstractThere is increasing research interest in using mesoporous silica for the delivery of poorly water-soluble drugs that are stabilized in a noncrystalline form. Most research has been done on ordered silica, whereas far fewer studies have been published on using nonordered mesoporous silica, and little is known about intrinsic drug affinity to the silica surface. The present mechanistic study uses inverse gas chromatography (IGC) to analyze the surface energies of three different commercially available disordered mesoporous silica grades in the gas phase. Using the more drug-like probe molecule octane instead of nitrogen, the concept of a “drug-accessible surface area” is hereby introduced, and the effect on drug monolayer capacity is addressed. In addition, enthalpic interactions of molecules with the silica surface were calculated based on molecular mechanics, and entropic energy contributions of volatiles were estimated considering molecular flexibility. These free energy contributions were used in a regression model, giving a successful comparison with experimental desorption energies from IGC. It is proposed that a simplified model for drugs based only on the enthalpic interactions can provide an affinity ranking to the silica surface. Following this preformulation research on mesoporous silica, future studies may harness the presented concepts to guide formulation scientists. © 2023 American Chemical Society.
dc.identifier.doi10.1021/acs.molpharmaceut.3c00690
dc.identifier.issn1543-8384
dc.identifier.issn1543-8392
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/44034
dc.issue12
dc.language.isoen
dc.publisherACS
dc.relation.ispartofMolecular Pharmaceutics
dc.subjectDrug-silica interaction prediction
dc.subjectInverse gas chromatography
dc.subjectMesoporous silica carrier
dc.subjectModeling-based prediction
dc.subjectMonolayer capacity
dc.subject.ddc600 - Technik, Medizin, angewandte Wissenschaften
dc.titleStudy of disordered mesoporous silica regarding intrinsic compound affinity to the carrier and drug-accessible surface area
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume20
dspace.entity.typePublication
fhnw.InventedHereYes
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publication
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.openAccessCategoryClosed
fhnw.pagination6301-6310
fhnw.publicationStatePublished
relation.isAuthorOfPublication06a3358a-d47d-4c9a-8527-ca95e717ed66
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery06a3358a-d47d-4c9a-8527-ca95e717ed66
Dateien

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Kein Vorschaubild vorhanden
Name:
license.txt
Größe:
1.36 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: